WO2007140188A3 - Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases - Google Patents

Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases Download PDF

Info

Publication number
WO2007140188A3
WO2007140188A3 PCT/US2007/069475 US2007069475W WO2007140188A3 WO 2007140188 A3 WO2007140188 A3 WO 2007140188A3 US 2007069475 W US2007069475 W US 2007069475W WO 2007140188 A3 WO2007140188 A3 WO 2007140188A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnostic
natriuretic peptides
vascular diseases
prognostic indicators
diagnosis
Prior art date
Application number
PCT/US2007/069475
Other languages
French (fr)
Other versions
WO2007140188A2 (en
Inventor
Kenneth F Buechler
Original Assignee
Biosite Inc
Kenneth F Buechler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosite Inc, Kenneth F Buechler filed Critical Biosite Inc
Priority to EP07797656A priority Critical patent/EP2024395A4/en
Publication of WO2007140188A2 publication Critical patent/WO2007140188A2/en
Publication of WO2007140188A3 publication Critical patent/WO2007140188A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis

Abstract

The present invention relates to methods for the diagnosis and evaluation of subclinical atherosclerosis. In particular, patient test samples are analyzed for the presence and amount of one or more natriuretic peptides. A variety of additional markers are disclosed for assembling a panel of markers for such diagnosis and evaluation.
PCT/US2007/069475 2006-05-26 2007-05-22 Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases WO2007140188A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07797656A EP2024395A4 (en) 2006-05-26 2007-05-22 Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80865506P 2006-05-26 2006-05-26
US60/808,655 2006-05-26

Publications (2)

Publication Number Publication Date
WO2007140188A2 WO2007140188A2 (en) 2007-12-06
WO2007140188A3 true WO2007140188A3 (en) 2008-07-10

Family

ID=38779325

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/069475 WO2007140188A2 (en) 2006-05-26 2007-05-22 Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases

Country Status (2)

Country Link
EP (1) EP2024395A4 (en)
WO (1) WO2007140188A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492107B2 (en) 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
JP5909447B2 (en) 2009-09-14 2016-04-26 バンヤン・バイオマーカーズ・インコーポレーテッド MicroRNAs, autoantibodies and protein markers for neuronal damage diagnosis
EP2742348A4 (en) 2011-08-12 2015-07-22 Alfred Health Method for diagnosis, prognosis or treatment of acute coronary syndrome (acs) comprising measurement of plasma concentration of macrophage migration inhibitory factor (mif)
WO2019061396A1 (en) * 2017-09-30 2019-04-04 Alfred Health Method of prognosis
BR112021008262A2 (en) * 2018-10-31 2021-10-26 Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (F.S.P.) SUBCLINICAL ATHEROSCLEROSIS BIOMARKERS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040203083A1 (en) * 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040203083A1 (en) * 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of EP2024395A4 *
VASAN: "Biomarkers of cardiovascular disease: molecular basis and practical considerations", CIRCULATION, vol. 113, no. 19, 16 May 2006 (2006-05-16), pages 2335 - 2362, XP002464236 *

Also Published As

Publication number Publication date
WO2007140188A2 (en) 2007-12-06
EP2024395A2 (en) 2009-02-18
EP2024395A4 (en) 2009-07-01

Similar Documents

Publication Publication Date Title
WO2008021290A3 (en) Organ-specific proteins and methods of their use
WO2012018535A3 (en) Wellness panel
WO2007030571A3 (en) Identification of targets and development of reagents for testing and molecular imaging of human disease
WO2006127861A3 (en) Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
WO2010041046A3 (en) Granin proteins as markers of heart disease
WO2006034427A3 (en) Diagnosis of fetal aneuploidy
WO2008055491A3 (en) Diagnosis and risk assessment of pancreatic diabetes using mr-proadm
WO2007117444A3 (en) Protein detection by aptamers
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
WO2010144150A3 (en) Real-time analytical methods and systems
WO2007047408A3 (en) Promac signature application
WO2009093254A3 (en) Methods and compositions for diagnosing complications of pregnancy
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
WO2007061906A3 (en) Diagnostic and therapeutics for cardiovascular disorders
WO2007140188A3 (en) Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
WO2009113814A3 (en) Protein marker for early diagnosis of liver cancer
WO2009029971A8 (en) Method for diagnosing the metabolic syndrome (ms)
WO2011015944A3 (en) Use of free dna as an early predictor of severity in acute pancreatitis
WO2008124091A3 (en) Compositions and methods of detection
WO2010046648A3 (en) Diagnostic test for streptococcus equi
WO2007084397A3 (en) Processing of slpi by chymase
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
WO2006099543A3 (en) Methods for assessing antibody-mediated cytotoxicity
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07797656

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007797656

Country of ref document: EP